Literature DB >> 16985869

Advances in brachytherapy.

Peter Grimm, John Sylvester.   

Abstract

During the past 15 years, permanent seed brachytherapy for prostate cancer has advanced significantly in all areas, including patient selection, treatment planning, technique, and technology (eg, seeds stranded in Vicryl suture). These improvements have made transperineal seed implantation an accurate and practical treatment option for men with low-, intermediate-, and high-risk disease. Because of the evidence that the various treatment options for prostate cancer are likely to be equally successful in terms of long-term cancer control, continuing efforts focus on enhancing the quality of life of implant patients.

Entities:  

Year:  2004        PMID: 16985869      PMCID: PMC1472866     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  61 in total

1.  Prostate brachytherapy seed migration to a coronary artery found during angiography.

Authors:  Brian J Davis; John F Bresnahan; Scott L Stafford; Barry L Karon; Bernard F King; Torrence M Wilson
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

2.  Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model.

Authors:  C C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  CT-based dosimetry for transperineal I-125 prostate brachytherapy.

Authors:  J Willins; K Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-09-01       Impact factor: 7.038

4.  Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer.

Authors:  G Kovács; R Galalae; T Loch; H Bertermann; P Kohr; R Schneider; B Kimming
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

5.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Authors:  M J Zelefsky; Z Fuks; M Hunt; H J Lee; D Lombardi; C C Ling; V E Reuter; E S Venkatraman; S A Leibel
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

6.  Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.

Authors:  G S Merrick; W M Butler; R W Galbreath; J H Lief
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

7.  Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration.

Authors:  Jeffrey S Eshleman; Brian J Davis; Thomas M Pisansky; Torrence M Wilson; Michael G Haddock; Bernard F King; Charles H Darby; Wayne N Lajoie; Ann L Oberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

8.  Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.

Authors:  Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

9.  Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies.

Authors:  A Martinez; G K Edmundson; R S Cox; L L Gunderson; A E Howes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-02       Impact factor: 7.038

10.  Short-term freedom from disease progression after I-125 prostate implantation.

Authors:  K Wallner; J Roy; M Zelefsky; Z Fuks; L Harrison
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-09-30       Impact factor: 7.038

View more
  5 in total

1.  Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.

Authors:  Luca F Valle; Matthew D Greer; Joanna H Shih; Tristan Barrett; Yan Mee Law; Andrew B Rosenkrantz; Haytham Shebel; Akhil Muthigi; Daniel Su; Maria J Merino; Bradford J Wood; Peter A Pinto; Andra V Krauze; Aradhana Kaushal; Peter L Choyke; Barış Türkbey; Deborah E Citrin
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

2.  Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.

Authors:  Jeffrey L Schaal; Xinghai Li; Eric Mastria; Jayanta Bhattacharyya; Michael R Zalutsky; Ashutosh Chilkoti; Wenge Liu
Journal:  J Control Release       Date:  2016-02-27       Impact factor: 9.776

Review 3.  Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH.

Authors:  Blake B Anderson; Joseph J Pariser; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

4.  Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants.

Authors:  Brent D Weinberg; Ravi B Patel; Hanping Wu; Elvin Blanco; Carlton C Barnett; Agata A Exner; Gerald M Saidel; Jinming Gao
Journal:  Med Biol Eng Comput       Date:  2008-06-04       Impact factor: 2.602

5.  Less-restrictive, patient-specific radiation safety precautions can be safely prescribed after permanent seed implantation.

Authors:  Lawrence T Dauer; Marisa A Kollmeier; Matthew J Williamson; Jean St Germain; Joaquin Altamirano; Yoshiya Yamada; Michael J Zelefsky
Journal:  Brachytherapy       Date:  2009-10-22       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.